Skip to content
10-K

Annual Report

CONSTELLATION PHARMACEUTICALS INC

0001564590-21-007783

← back to feed
Filed
Feb 24, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 19, 2021 47.86M sh
Capex FY 2020 · Dec 31, 2020 $946K
Capex FY 2020 · Dec 31, 2019 $699K
Capex FY 2020 · Dec 31, 2018 $476K
Operating Cash Flow FY 2020 · Dec 31, 2020 −$111.42M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$72.25M
Operating Cash Flow FY 2020 · Dec 31, 2018 −$48.82M
Cash And Equivalents FY 2020 · Dec 31, 2020 $163.69M
Cash And Equivalents FY 2020 · Dec 31, 2019 $334.33M
Stockholders Equity FY 2020 · Dec 31, 2020 $410.72M
Stockholders Equity FY 2020 · Dec 31, 2019 $337.58M
Stockholders Equity FY 2020 · Dec 31, 2018 $104.16M
Stockholders Equity FY 2020 · Dec 31, 2017 −$165.83M
Current Liabilities FY 2020 · Dec 31, 2020 $30.55M
Current Liabilities FY 2020 · Dec 31, 2019 $22.76M
Total Liabilities FY 2020 · Dec 31, 2020 $31.13M
Total Liabilities FY 2020 · Dec 31, 2019 $61.55M
Current Assets FY 2020 · Dec 31, 2020 $428.61M
Current Assets FY 2020 · Dec 31, 2019 $386.99M
Total Assets FY 2020 · Dec 31, 2020 $441.85M
Total Assets FY 2020 · Dec 31, 2019 $399.13M
Sga Expense FY 2020 · Dec 31, 2020 $29.35M
Sga Expense FY 2020 · Dec 31, 2019 $19.6M
Sga Expense FY 2020 · Dec 31, 2018 $12.48M
Rd Expense FY 2020 · Dec 31, 2020 $95.5M
Rd Expense FY 2020 · Dec 31, 2019 $66.46M
Rd Expense FY 2020 · Dec 31, 2018 $48.77M
Net Income FY 2020 · Dec 31, 2020 −$37.38M
Net Income FY 2020 · Dec 31, 2020 −$126.36M
Net Income FY 2020 · Sep 30, 2020 −$33.78M
Net Income FY 2020 · Jun 30, 2020 −$29.75M
Net Income FY 2020 · Mar 31, 2020 −$25.44M
Net Income FY 2020 · Dec 31, 2019 −$24.21M
Net Income FY 2020 · Dec 31, 2019 −$85.55M
Net Income FY 2020 · Sep 30, 2019 −$21.15M
Net Income FY 2020 · Jun 30, 2019 −$20.77M
Net Income FY 2020 · Mar 31, 2019 −$19.43M
Net Income FY 2020 · Dec 31, 2018 −$59.93M
Operating Income FY 2020 · Dec 31, 2020 −$124.85M
Operating Income FY 2020 · Dec 31, 2019 −$86.06M
Operating Income FY 2020 · Dec 31, 2018 −$61.24M
Long Term Debt FY 2020 · Dec 31, 2019 $29.64M